{"id":1901,"date":"2024-11-21T11:52:42","date_gmt":"2024-11-21T10:52:42","guid":{"rendered":"https:\/\/www.pharmanager-development.com\/?post_type=sector&#038;p=1901"},"modified":"2025-02-03T12:25:19","modified_gmt":"2025-02-03T11:25:19","slug":"biocidal-products","status":"publish","type":"sector","link":"https:\/\/www.pharmanager-development.com\/en\/secteur\/biocidal-products\/","title":{"rendered":"Biocides"},"content":{"rendered":"\n<section id=\"block_80a8a522ea76b690d25f9dcb21b8dec9\" class=\" section section_header-block section_header-bg-img\" style=\"background-image: url('https:\/\/www.pharmanager-development.com\/wp-content\/uploads\/2024\/11\/Biocides.jpg');\">\n            <div class=\"breadcrumbs\">\n            <div class=\"yoast-breadcrumb\"><span><span><a href=\"https:\/\/www.pharmanager-development.com\/en\/\">Accueil<\/a><\/span><\/span><\/div>        <\/div>\n        <div class=\"header-block_container\">\n        <div class=\"container \">\n            <div class=\"header_content\">\n                                    <h1 style=\"text-align: center; color: #ffffff;\"><span style=\"color: #ffffff;\">Biocides<\/span><\/h1>\n<p><span style=\"color: #ffffff;\">At Pharmanager Development, we leverage our expertise to support you in the development and compliance of your biocidal products. These products, composed of one or more active substances, are designed to eliminate, repel, or neutralize harmful organisms. They play a key role in protecting human, animal, and environmental health.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n                \n                            <\/div>\n                    <\/div>\n    <\/div>\n<\/section>\n\n\n\n<section id=\"block_9a07b3b16c2353794529aef91dc06f99\" class=\" section section_content-icon-block section_content-icon-no-bg\" >\n            <div class=\"content-icon-block_container container\">\n            <div class=\"content-icon-title\">\n                <h2 style=\"text-align: center;\">What Regulations Apply to Biocidal Products?<\/h2>\n<p>Biocidal products are classified into 22 product types based on their intended use. These include specific categories such as veterinary hygiene products, disinfectants for surfaces not intended for humans or animals, and repellents or baits for pests.<\/p>\n<p>Our team, which includes a specialized toxicologist, ensures a comprehensive approach to guarantee the safety, performance, and compliance of your products in Europe.<\/p>\n<p>The European market authorization of such products is governed by specific regulations that ensure both compliance and safe use.<\/p>\n            <\/div>\n        <\/div>\n                <div class=\"content-icon_container container\" style=\"--process-count: 3\">\n                                    <div class=\"content-icon_item \" >\n                                                    <div class=\"content-icon-title\">\n                                                                    <span class=\"icon icon-balance\"><\/span>\n                                                                                                        <h3><strong>528\/2012<\/strong>\/EU<\/h3>\n                                                            <\/div>\n                                                                            <div class=\"content-icon-content\">\n                                <p>This regulation establishes the rules for the marketing and use of biocidal products within the European Union. It covers the approval of active substances, product authorization, and labeling and safety requirements, ensuring effective protection for users and the environment.<\/p>\n                            <\/div>\n                                            <\/div>\n                                    <div class=\"content-icon_item \" >\n                                                    <div class=\"content-icon-title\">\n                                                                    <span class=\"icon icon-balance\"><\/span>\n                                                                                                        <h3><strong>1272\/2008<\/strong>\/EC<\/h3>\n                                                            <\/div>\n                                                                            <div class=\"content-icon-content\">\n                                <p>This regulation harmonizes the classification, labeling, and packaging of chemical products, including biocides. It mandates hazard statements, safety pictograms, and notification to poison control centers (toxicovigilance) to ensure clear information and controlled product use.<\/p>\n                            <\/div>\n                                            <\/div>\n                                    <div class=\"content-icon_item \" >\n                                                    <div class=\"content-icon-title\">\n                                                                    <span class=\"icon icon-balance\"><\/span>\n                                                                                                        <h3><strong>1907\/2006<\/strong>\/<strong>EC<\/strong><\/h3>\n                                                            <\/div>\n                                                                            <div class=\"content-icon-content\">\n                                <p>This regulation aims to secure the production and use of chemical substances through a reinforced traceability system. It requires manufacturers to provide appropriate Safety Data Sheets (SDS) and ensure regulatory compliance of the substances used in biocidal products.<\/p>\n                            <\/div>\n                                            <\/div>\n                            <\/div>\n    <\/section>\n\n\n<section id=\"block_06bffd803f199df704715859d19446e8\" class=\"stafe-blocks-content sbc section section_content-block section_content-bg-color\" style=\"background-color: #f8f9fa;\">\n        <div class=\"content-block_container\">\n        <div class=\"container content-container-right-accordion\">\n            \n            \n                            <div class=\"content_accordion\">\n                                            <div class=\"accordion_item\">\n                                    <span class=\"accordion-title\">\n                                        <h3><span class=\"fourth-title\">Verification and Validation of Compliance <\/span><\/h3>\n                                        <span class=\"btn btn-brown\">\n                                            <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                        <\/span>\n                                    <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"sixth-title\">We analyze the composition and labeling of your biocidal products to ensure compliance with Regulation (EU) No. 528\/2012 and Regulation (EC) No. 1272\/2008, as well as applicable national regulations.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"accordion_item\">\n                                    <span class=\"accordion-title\">\n                                        <h3><strong><span class=\"fourth-title\">Marketing Authorization Dossier Preparation<\/span><\/strong><\/h3>\n                                        <span class=\"btn btn-brown\">\n                                            <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                        <\/span>\n                                    <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"sixth-title\">We prepare your market authorization dossiers for finished products, including scientific, technical, and safety data, to meet the requirements of competent authorities.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"accordion_item\">\n                                    <span class=\"accordion-title\">\n                                        <h3><strong><span class=\"fourth-title\">Registrations and Declarations Management <\/strong><\/h3>\n                                        <span class=\"btn btn-brown\">\n                                            <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                        <\/span>\n                                    <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"sixth-title\">We handle administrative procedures, including specific national processes, to ensure a smooth and compliant market entry for your biocidal products.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"accordion_item\">\n                                    <span class=\"accordion-title\">\n                                        <h3><strong><span class=\"fourth-title\">Support for a New Active Substance <\/strong><\/h3>\n                                        <span class=\"btn btn-brown\">\n                                            <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                        <\/span>\n                                    <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"sixth-title\">We guide you through the approval process for a new active substance in accordance with Regulation (EU) No. 528\/2012, ensuring compliance with the highest standards.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"accordion_item\">\n                                    <span class=\"accordion-title\">\n                                        <h3><strong><span class=\"fourth-title\">Regulatory Monitoring on Biocides <\/strong><\/h3>\n                                        <span class=\"btn btn-brown\">\n                                            <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                        <\/span>\n                                    <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"sixth-title\">We track legislative developments in Europe to keep you informed of regulatory changes affecting your products and help you adapt your strategies accordingly.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                    <\/div>\n            \n            <div class=\"content_content\">\n                                    <h2>Pharmanager Development Supports You In:<\/h2>\n<p>We assist you at every stage of your biocidal products&#8217; lifecycle, from their initial design to market entry. With our unique expertise and the involvement of our specialized toxicologist, we help ensure the safety of your formulations, regulatory compliance, and approval by competent authorities.<\/p>\n<p>Whether it\u2019s developing new active substances, demonstrating product efficacy, or validating labeling, our team provides comprehensive and tailored support. We are committed to maximizing your success in the European market by anticipating legislative requirements and ensuring flawless compliance.<\/p>\n                \n                                    <div class=\"content_cta\">\n                                                                                    <a href=\"https:\/\/www.pharmanager-development.com\/en\/contact\/\" class=\"btn btn-gradient-primary \" target=\"\">\n                                    <span>Contact us<\/span>\n                                                                    <\/a>\n                                                                        <\/div>\n                            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n<section id=\"block_250f38716692670cd31921423af6520e\" class=\" section section_news-block section_news-no-bg\" >\n    <div class=\"news-block_container container\">\n                                    <div class=\"news_content\">\n                    <div class=\"news-title\">\n                        <h2>Explore Our Case Studies<\/h2>\n                    <\/div>\n                                            <div class=\"news-cta\">\n                                                                                                <a href=\"https:\/\/www.pharmanager-development.com\/en\/news\/\" class=\"btn btn-gradient-primary \" target=\"\">\n                                        <span>View all case studies<\/span>\n                                                                            <\/a>\n                                                                                    <\/div>\n                    \n                <\/div>\n                                                            <div class=\"news_grid\">\n                                            <div class=\"new_item\">\n                            <div class=\"new_item-img\">\n                                <div class=\"new_item-wrapper\">\n                                    <img decoding=\"async\" src=\"https:\/\/www.pharmanager-development.com\/wp-content\/uploads\/2025\/01\/Site-internet-PDEV-21.jpg\" alt=\"\">\n                                <\/div>\n                            <\/div>\n                            <div class=\"new_item-content\">\n                                <span class=\"new_item-date\">\n                                    <span class=\"icon icon-calendar_month\"><\/span>\n                                    28 January 2025                               <\/span>\n                                <span class=\"new_item-title third-title\">\n                                    <a href=\"https:\/\/www.pharmanager-development.com\/en\/case-studies-biocides-2\/\">Biocides: Comparative analysis of regulation, effectiveness, and reclassification risks<\/a>\n                                <\/span>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"new_item\">\n                            <div class=\"new_item-img\">\n                                <div class=\"new_item-wrapper\">\n                                    <img decoding=\"async\" src=\"https:\/\/www.pharmanager-development.com\/wp-content\/uploads\/2025\/01\/Site-internet-PDEV-31-e1736370404104.jpg\" alt=\"\">\n                                <\/div>\n                            <\/div>\n                            <div class=\"new_item-content\">\n                                <span class=\"new_item-date\">\n                                    <span class=\"icon icon-calendar_month\"><\/span>\n                                    8 January 2025                               <\/span>\n                                <span class=\"new_item-title third-title\">\n                                    <a href=\"https:\/\/www.pharmanager-development.com\/en\/audit-cosmetic-positioning-avoid-risky-claims-ensure-compliance\/\">Audit of cosmetic product positioning: understanding and avoiding risks<\/a>\n                                <\/span>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"new_item\">\n                            <div class=\"new_item-img\">\n                                <div class=\"new_item-wrapper\">\n                                    <img decoding=\"async\" src=\"https:\/\/www.pharmanager-development.com\/wp-content\/uploads\/2025\/01\/Biocides-.jpg\" alt=\"\">\n                                <\/div>\n                            <\/div>\n                            <div class=\"new_item-content\">\n                                <span class=\"new_item-date\">\n                                    <span class=\"icon icon-calendar_month\"><\/span>\n                                    7 January 2025                               <\/span>\n                                <span class=\"new_item-title third-title\">\n                                    <a href=\"https:\/\/www.pharmanager-development.com\/en\/case-study-regulation-and-effectiveness-of-anti-lice-sprays\/\">Case study: regulation and effectiveness of anti-lice sprays<\/a>\n                                <\/span>\n                            <\/div>\n                        <\/div>\n                                    <\/div>\n                                    <\/div>\n<\/section>\n\n<script>\n    var theme_directory = \"https:\/\/www.pharmanager-development.com\/wp-content\/themes\/pharmanager-development\";\n<\/script>\n\n\n<section id=\"block_78cdd1826e745748c4edb43f4fa87811\" class=\"stafe-blocks-faq sbfaq section section_faq-block section_faq-bg-color\" style=\"background-color: #f8f9fa;\">\n    <script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"<h3><span class=\\\"third-title\\\">How to Obtain a Market Authorization for a Biocidal Product?<\\\/span><\\\/h3>\\n\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><span class=\\\"fourth-title\\\">For biocidal products requiring authorization, a comprehensive dossier must be submitted, including data on safety, efficacy, and environmental impact. We assist you in the preparation and submission of this dossier.<\\\/span><\\\/p>\\n\"}},{\"@type\":\"Question\",\"name\":\"<h3><span class=\\\"third-title\\\">What Are the Labeling Requirements for Biocidal Products?<\\\/span><br \\\/>\\n<span class=\\\"third-title\\\">\\u00a0<\\\/span><\\\/h3>\\n\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><span class=\\\"fourth-title\\\">Labeling must comply with the Biocidal Products Regulation (EU 528\\\/2012) for biocidal claims and the CLP Regulation (EC 1272\\\/2008) if the product is classified as hazardous.<\\\/span><\\\/p>\\n\"}},{\"@type\":\"Question\",\"name\":\"<h3><span class=\\\"third-title\\\">Can I Use Any Substance to Achieve the Desired Effect in My Biocidal Product?<\\\/span><\\\/h3>\\n\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><span class=\\\"fourth-title\\\">No. Only specific approved substances listed in various official registers can be used as biocidal active substances (AS):<\\\/span><\\\/p>\\n<p><span class=\\\"fourth-title\\\">AS officially approved at the EU level (maintained by the European Chemicals Agency, ECHA).<\\\/span><br \\\/>\\n<span class=\\\"fourth-title\\\">AS listed in Annex I of Regulation (EU) 528\\\/2012 (Biocidal Regulation).<\\\/span><br \\\/>\\n<span class=\\\"fourth-title\\\">AS included in Regulation (EU) 1062\\\/2014 (Review Program).<\\\/span><br \\\/>\\n<span class=\\\"fourth-title\\\">It is important to note that these substances are often restricted to specific product types (PTs). For example, if a substance is only approved for PT1 (Human Hygiene), it cannot be used in a product claiming effects related to PT2 (Surface Disinfection).<\\\/span><\\\/p>\\n<p><span class=\\\"fourth-title\\\">Additionally, active substances must be sourced from approved suppliers, except for those listed in Annex I of the Biocidal Regulation. Approved suppliers are listed in the Article 95 List, maintained by ECHA.<\\\/span><\\\/p>\\n\"}},{\"@type\":\"Question\",\"name\":\"<h3><span class=\\\"third-title\\\">Quelles sont les obligations en mati\\u00e8re d\\u2019\\u00e9tiquetage des produits biocides ?<\\\/span><\\\/h3>\\n\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p><span class=\\\"fourth-title\\\">L\\u2019\\u00e9tiquetage doit \\u00eatre conforme au\\u00a0r\\u00e8glement CLP (CE) n\\u00b0 1272\\\/2008\\u00a0et inclure des mentions de danger, des pictogrammes, et des instructions d\\u2019utilisation.<\\\/span><\\\/p>\\n\"}},{\"@type\":\"Question\",\"name\":\"<h3><span class=\\\"third-title\\\">What Is the Procedure for Placing a Biocidal Product on the Market?<\\\/span><\\\/h3>\\n\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"<p>There are two main <strong>market authorization procedures<\\\/strong> depending on the active substances used and the claimed efficacy:<\\\/p>\\n<p>1\\ufe0f\\u20e3 <strong>Standard Procedure (Permanent Regime)<\\\/strong><\\\/p>\\n<ul>\\n<li>This is the <strong>regular and final regime<\\\/strong>, which will eventually be the only one in effect.<\\\/li>\\n<li>It requires obtaining a <strong>market authorization (MA)<\\\/strong> for each biocidal product.<\\\/li>\\n<li>This procedure applies when <strong>all active substances in the product are officially approved<\\\/strong> for the claimed efficacy.<\\\/li>\\n<\\\/ul>\\n<p>2\\ufe0f\\u20e3 <strong>Transitional Regime<\\\/strong><\\\/p>\\n<ul>\\n<li>In some cases, regulations allow the <strong>marketing of biocidal products containing active substances that are not yet officially approved<\\\/strong>.<\\\/li>\\n<li>To qualify, the biocidal product must contain an <strong>active substance listed in Regulation (EU) 1062\\\/2014<\\\/strong>.<\\\/li>\\n<li>Under this regime, an <strong>MA is generally not required<\\\/strong> (except in rare cases). Instead, <strong>national regulations of the country where the product is marketed apply<\\\/strong> for labeling and registration requirements.<\\\/li>\\n<\\\/ul>\\n\"}}]}<\/script>\n    <div class=\"faq-block_container\">\n        <div class=\"container\">\n                            <div class=\"faq_title\">\n                    <h2 style=\"text-align: center;\">Our Answers to Your Questions<\/h2>\n                <\/div>\n            \n                            <div class=\"faq_accordion\">\n                                            <div class=\"faq_item\">\n                            <span class=\"accordion-title\">\n                                <h3><span class=\"third-title\">How to Obtain a Market Authorization for a Biocidal Product?<\/span><\/h3>\n                                <span class=\"btn btn-brown\">\n                                    <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                <\/span>\n                            <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"fourth-title\">For biocidal products requiring authorization, a comprehensive dossier must be submitted, including data on safety, efficacy, and environmental impact. We assist you in the preparation and submission of this dossier.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"faq_item\">\n                            <span class=\"accordion-title\">\n                                <h3><span class=\"third-title\">What Are the Labeling Requirements for Biocidal Products?<\/span><br \/>\n<span class=\"third-title\">\u00a0<\/span><\/h3>\n                                <span class=\"btn btn-brown\">\n                                    <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                <\/span>\n                            <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"fourth-title\">Labeling must comply with the Biocidal Products Regulation (EU 528\/2012) for biocidal claims and the CLP Regulation (EC 1272\/2008) if the product is classified as hazardous.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"faq_item\">\n                            <span class=\"accordion-title\">\n                                <h3><span class=\"third-title\">Can I Use Any Substance to Achieve the Desired Effect in My Biocidal Product?<\/span><\/h3>\n                                <span class=\"btn btn-brown\">\n                                    <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                <\/span>\n                            <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"fourth-title\">No. Only specific approved substances listed in various official registers can be used as biocidal active substances (AS):<\/span><\/p>\n<p><span class=\"fourth-title\">AS officially approved at the EU level (maintained by the European Chemicals Agency, ECHA).<\/span><br \/>\n<span class=\"fourth-title\">AS listed in Annex I of Regulation (EU) 528\/2012 (Biocidal Regulation).<\/span><br \/>\n<span class=\"fourth-title\">AS included in Regulation (EU) 1062\/2014 (Review Program).<\/span><br \/>\n<span class=\"fourth-title\">It is important to note that these substances are often restricted to specific product types (PTs). For example, if a substance is only approved for PT1 (Human Hygiene), it cannot be used in a product claiming effects related to PT2 (Surface Disinfection).<\/span><\/p>\n<p><span class=\"fourth-title\">Additionally, active substances must be sourced from approved suppliers, except for those listed in Annex I of the Biocidal Regulation. Approved suppliers are listed in the Article 95 List, maintained by ECHA.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"faq_item\">\n                            <span class=\"accordion-title\">\n                                <h3><span class=\"third-title\">Quelles sont les obligations en mati\u00e8re d\u2019\u00e9tiquetage des produits biocides ?<\/span><\/h3>\n                                <span class=\"btn btn-brown\">\n                                    <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                <\/span>\n                            <\/span>\n                            <div class=\"accordion-content\">\n                                <p><span class=\"fourth-title\">L\u2019\u00e9tiquetage doit \u00eatre conforme au\u00a0r\u00e8glement CLP (CE) n\u00b0 1272\/2008\u00a0et inclure des mentions de danger, des pictogrammes, et des instructions d\u2019utilisation.<\/span><\/p>\n                            <\/div>\n                        <\/div>\n                                            <div class=\"faq_item\">\n                            <span class=\"accordion-title\">\n                                <h3><span class=\"third-title\">What Is the Procedure for Placing a Biocidal Product on the Market?<\/span><\/h3>\n                                <span class=\"btn btn-brown\">\n                                    <span class=\"icon icon-keyboard_arrow_down\"><\/span>\n                                <\/span>\n                            <\/span>\n                            <div class=\"accordion-content\">\n                                <p>There are two main <strong>market authorization procedures<\/strong> depending on the active substances used and the claimed efficacy:<\/p>\n<p>1\ufe0f\u20e3 <strong>Standard Procedure (Permanent Regime)<\/strong><\/p>\n<ul>\n<li>This is the <strong>regular and final regime<\/strong>, which will eventually be the only one in effect.<\/li>\n<li>It requires obtaining a <strong>market authorization (MA)<\/strong> for each biocidal product.<\/li>\n<li>This procedure applies when <strong>all active substances in the product are officially approved<\/strong> for the claimed efficacy.<\/li>\n<\/ul>\n<p>2\ufe0f\u20e3 <strong>Transitional Regime<\/strong><\/p>\n<ul>\n<li>In some cases, regulations allow the <strong>marketing of biocidal products containing active substances that are not yet officially approved<\/strong>.<\/li>\n<li>To qualify, the biocidal product must contain an <strong>active substance listed in Regulation (EU) 1062\/2014<\/strong>.<\/li>\n<li>Under this regime, an <strong>MA is generally not required<\/strong> (except in rare cases). Instead, <strong>national regulations of the country where the product is marketed apply<\/strong> for labeling and registration requirements.<\/li>\n<\/ul>\n                            <\/div>\n                        <\/div>\n                                    <\/div>\n                                <\/div>\n    <\/div>\n<\/section>\n\n\n\n<div style=\"height:16px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<section id=\"block_92bb7ff4cb140ea077cfe2d1613013d0\" class=\"section section_push-block\">\n    <div class=\"container\">\n        <div class=\"push-block_container push-container-large push-container-gradient-primary \" >\n                            <div class=\"push_content\">\n                    <h2 style=\"color: #fff;\">Need Advice or Expert Support in This Evolving and Increasingly Stringent Regulatory Context?<\/h2>\n                <\/div>\n            \n                        <div class=\"push_cta\">\n                                                                                                        <a href=\"https:\/\/www.pharmanager-development.com\/en\/contact\/\" class=\"btn btn-white \" target=\"\">\n                                <span>Contact us<\/span>\n                                                            <\/a>\n                                                                        <\/div>\n                    <\/div>\n    <\/div>\n<\/section>\n","protected":false},"featured_media":1488,"parent":0,"menu_order":0,"template":"","class_list":["post-1901","sector","type-sector","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharmanager Development<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:site_name\" content=\"Pharmanager Development\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"CollectionPage\",\"@id\":null,\"url\":\"\",\"name\":\"\",\"isPartOf\":{\"@id\":\"https:\/\/www.pharmanager-development.com\/en\/#website\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pharmanager-development.com\/en\/#website\",\"url\":\"https:\/\/www.pharmanager-development.com\/en\/\",\"name\":\"Pharmanager Development\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pharmanager-development.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmanager Development","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"\/","og_locale":"en_US","og_type":"article","og_site_name":"Pharmanager Development","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"CollectionPage","@id":null,"url":"","name":"","isPartOf":{"@id":"https:\/\/www.pharmanager-development.com\/en\/#website"},"inLanguage":"en-US"},{"@type":"WebSite","@id":"https:\/\/www.pharmanager-development.com\/en\/#website","url":"https:\/\/www.pharmanager-development.com\/en\/","name":"Pharmanager Development","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pharmanager-development.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/sector\/1901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/sector"}],"about":[{"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/types\/sector"}],"version-history":[{"count":5,"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/sector\/1901\/revisions"}],"predecessor-version":[{"id":2830,"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/sector\/1901\/revisions\/2830"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/media\/1488"}],"wp:attachment":[{"href":"https:\/\/www.pharmanager-development.com\/en\/wp-json\/wp\/v2\/media?parent=1901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}